Zidovudine and thymus humoral factor gamma-2 in the treatment of HIV infection: Preliminary clinical experience
Infection1997Vol. 25(1), pp. 35–38
Franco Maggiolo, Alberto Taras, Fredy Suter, Maria Grazia Pravettoni, Manuela Leone, Antonella Ingrosso
Related Papers
- → Manifestaciones dermatológicas asociadas a la infección por VIH/SIDA(2015)30 cited
- → Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective study.(1987)22 cited
- → Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection(1990)71 cited
- → Correction of human immunodeficiency virus-associated depression of delayed-type hypersensitivity (DTH) after zidovudine therapy: DTH, CD4+ T-cell numbers, and epidermal Langerhans cell density are independent variables(1990)25 cited
- [Prevention of opportunistic infections in adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy. Recommendations of the Grupo de Estudio del SIDA (GESIDA/Plan National sobre el SIDA].(2000)